If I had a dollar for every pharma strategy deck that used "omnichannel" as a goal without defining what it actually means in practice, I could retire comfortably. The word has been so overused it has lost most of its signal. Teams say "omnichannel" and mean everything from "we have a website and a rep force" to "we have a fully integrated, data-driven engagement model." These are not the same thing.
So let's reset. What does genuine omnichannel actually look like in life sciences commercial — and what gets mistaken for it?
What Omnichannel Is Not
Running multiple channels in parallel is multichannel. It's not nothing — it's actually where most pharma companies still operate — but it's not omnichannel. In a multichannel model, your field force does its thing, your digital team does its thing, your medical affairs team does its thing, and occasionally they talk to each other. The customer experience is the sum of those parts, not the product of a coordinated strategy.
Having a CRM system doesn't make you omnichannel either. A CRM that captures field interactions but isn't connected to digital engagement data, isn't read by the digital team, and isn't generating orchestration logic is just an expensive contact log.
What Omnichannel Actually Requires
Real omnichannel has three core properties. First, a unified customer data layer — a model of each HCP or patient that integrates signals across channels in something close to real time. Second, orchestration logic — rules or AI that determine what message, from what channel, at what cadence, based on what the customer has done and not done. Third, closed-loop measurement — a feedback mechanism that tells you which channel sequences are actually driving behavior change, and continuously refines the model.
Omnichannel is not a channel strategy. It's a data and orchestration capability that channels plug into.
Most pharma organizations have version one of the first requirement — some data integration exists. Very few have version one of the second. Almost none have version three done well.
Why It's Hard in Life Sciences Specifically
The barriers are real. Privacy regulation limits what digital data can be tied to identifiable HCPs. Medical-legal-regulatory review cycles were designed for a world where content went out in batches, not dynamically personalized at the individual level. Field force incentive structures often don't reward the kind of orchestrated hand-offs that omnichannel requires. And the technology stack that would enable true orchestration — CRM, marketing automation, CDP, content management — has historically been fragmented, expensive, and hard to integrate.
None of this is insurmountable. But it does mean that building genuine omnichannel capability in pharma requires changes that go well beyond the digital team — into field force strategy, commercial operations, medical affairs, and IT. Organizations that treat it as a marketing project consistently underinvest and underdeliver.
Where to Start
My recommendation is almost always to start with the data layer and a single high-value channel pair, rather than trying to build the full orchestration model at once. Pick a launch brand or a therapeutic area where you have good data coverage. Map the customer journey carefully. Build the integration between two channels — say, field force and email — and instrument it so you can measure the impact of coordinated vs. uncoordinated outreach. Learn from that, then expand.
Omnichannel is a journey, not a destination. The companies making the most progress are the ones who've stopped pretending they've arrived and started doing the unglamorous work of connecting their data, aligning their teams, and measuring what actually moves the needle.
Ready to get real about your omnichannel strategy?
I help commercial teams cut through the noise and build engagement models that actually work — from data architecture to channel orchestration.
Let's talk →